Status:
ACTIVE_NOT_RECRUITING
Vestibular Outcomes in Vestibular Schwannoma
Lead Sponsor:
Haukeland University Hospital
Conditions:
Vestibular Schwannoma
Eligibility:
All Genders
Brief Summary
Previous studies have shown that vertigo is the symptoms that mostly affect quality of life in patients with vestibular schwannoma. There is still limited knowledge as to why some patients with this d...
Detailed Description
This is a longitudinal observational study with data collected at baseline and after treatment. Variables collected at baseline include age, sex, tumor size, location, type (cystic/solid), tumor side...
Eligibility Criteria
Inclusion
- Patients living i Norway referred to Haukeland University Hospital due to newly diagnosed, untreated vestibular schwannoma
Exclusion
- Inability to undergo test protocol due to physical or language barriers
Key Trial Info
Start Date :
April 23 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT03346889
Start Date
April 23 2017
End Date
December 31 2025
Last Update
October 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Hordaland, Norway, 5009